News
Manel Esteller,Vanguardia Science Award
The researcher Manel Esteller, Director of Epigenetics and Cancer Biology program at the Institute of Biomedical Research of Bellvitge (IDIBELL ), ICREA researcher and professor of Genetics at the University of Barcelona has won the Vanguardia Award for Science 2013. The selected job has been published in 2013 in the journal Genome Research and shows […]
Gonzalo Arévalo: ”10% of H2020 funding goes directly to Health but there are other areas that can provide opportunities for researchers”
The first calls of the European Horizon 2020 program have begun. On 17 January, the National Contact Point for Legal and Financial Affairs also part of the team of the Office of European Institute of Health Carlos III Project, Gonzalo Arévalo told investigators IDIBELL funding opportunities that may represent Horizon 2020 (H2020). “Between 25 and […]
An international study allows a better prediction of the risk of hereditary cancer
The paper analyzes the role of different genetic variants involved in Lynch syndrome , an inherited disease that increases the risk of various tumors The study is published in the journal Nature Genetics and has had the participation of Gabriel Capellá and Marta Pineda, form the Hereditary Cancer Program at the Catalan Institute of Oncology […]
Researchers discover a tumor suppressor gene in a very aggressive lung cancer
The Genes and Cancer Group at the Cancer Epigenetics and Biology Program of the IDIBELL has found that the MAX gene, which encodes a partner of the MYC oncogene, is genetically inactivated in small cell lung cancer. Reconstitution of MAX significantly reduced cell growth in the MAX-deficient cancer cell lines. These findings show that MAX […]
Researchers propose an alternative therapy to fight testicular cancer refractory to chemotherapy
Researchers at Tumor angiogenesis group at Bellvitge Biomedical Institute of Research (IDIBELL) and the Catalan Institute of Oncology (ICO) led by Francesc Viñals have published a study in the journal Clinical Cancer Research where they propose an alternative treatment to cisplatin resistant testicular cancer patients . 90 % cure rate of testicular tumors Testicular tumor […]
A free web application developed by the ICO-IDIBELL enables data analysis new generation sequencing
The last two years have seen a significant change in the field of genetic diagnosis , mainly due to the application of technologies next generation sequencing (NGS , next generation sequencing) in medium-capacity devices. The development of these instruments, together with the launch of commercial kits to study a limited number of genes, has allowed […]
Horizon 2020 launched with €15 billion over first two years
The European Commission has for the first time presented calls for projects under Horizon 2020, the European Union’s €80 billion research and innovation programme. Worth more than €15 billion over the first two years, the funding is intended to help boost Europe’s knowledge-driven economy, and tackle issues that will make a difference in people’s lives. […]
Keeping growth in check
Researchers from the Laboratory of Cancer Metabolism (LCM) led by George Thomas at the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO) and the Division of Hematology/ Oncology, University of Cincinnati, have shown that loss of either one of two tumor suppressors, ribosomal proteins RPL5 or RPL11, fail to induce cell-cycle arrest, […]